Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1053 (LINC01053)

Target
LINC01053
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA)
01

Overview

Long intergenic non-protein coding RNA 1053 (LINC01053) is a non-protein coding gene transcribing a lincRNA, a subclass of long non-coding RNAs (lncRNAs) that do not overlap protein-coding genes. LincRNAs serve regulatory functions in the genome including fine-tuning gene expression, altering chromatin architecture, stabilizing RNA molecules, and modulating transcriptional processes, often with marked tissue specificity. While some lincRNAs are implicated in human diseases such as cancer, few individual members (including LINC01053) have been thoroughly characterized with respect to clinical roles or direct molecular interactions. LINC01053 is cataloged in human genomic databases (NCBI, Ensembl), but as a non-coding RNA, it is not considered a traditional therapeutic drug target. LINC01053 is neither a receptor, enzyme, nor conventional drug target; it is a lincRNA gene, classified within the long non-coding RNA family, and functions mainly in epigenetic/transcriptional regulation. LincRNAs contribute to gene expression regulation, chromatin dynamics, and may act as enhancers or scaffolds for protein complexes. While some lincRNAs have emerging roles in cancer or other diseases, specific roles for LINC01053 remain uncharacterized. No therapeutic drugs, mechanisms of action, or safety concerns are specifically linked to LINC01053. If details on lincRNAs as a class are required, there is abundant literature on their role in gene regulation and human disease, but for LINC01053 specifically, available information remains basic and descriptive.

Other names
LINC01053
02

Biological functions

Regulation of gene expression (often neighboring genes)Chromatin remodelingRNA stabilizationTranscription regulation, including enhancer-associated activity
03

Disease associations

Other (lincRNAs are implicated in diverse diseases, especially cancer; no direct evidence provided for LINC01053 itself)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1053 (LINC01053).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1053 (LINC01053).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call